PNPLA2 and hepatocellular carcinoma: Overexpression of ATGL promotes glycolytic‐to‐oxidative metabolic switch and cell proliferation in parallel with increased oxidative metabolism of fatty acids and enhanced mitochondrial capacity in hepatocellular carcinoma cells, which reflects ATGL function as tumor suppressor [64].